P2B-006

State Health Centre Oncology Department (Budapest, Hungary) › P2B-006

P2B-006

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
State Health Centre Oncology Department (Budapest, Hungary) · Dr. Clarke
consented 2012-05-05

completed

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 decreased appetite with onset in cycle 5 (2012-08-13); assessed as not related to study drug (not related); resolved 2012-09-09.

mild assessed

Grade 3 neutropenia with onset in cycle 3 (2012-07-09); assessed as related to study drug (probable); resolved 2012-07-19.

severe assessed

Grade 2 vomiting with onset in cycle 3 (2012-06-29); assessed as not related to study drug (not related); resolved 2012-06-30.

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.